Medication info
Candesartan 8 mg Tablets (Candesartan Cilexetil)

Candesartan 8 mg Tablets (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›8mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
Light pink, round tablets with a convex shape on both sides
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201906419 · Approved 2019.09.11 · Insurance code 694002610

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
This drug should be taken at the same time each day, with or without food. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil, administered orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks after starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: For patients at increased risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful attention. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks and increased up to a maximum of 32 mg once daily, taking the patient's tolerability into account. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension The safety and efficacy in adolescents and children aged 18 years or younger have not been established. 2. Heart failure The safety and efficacy in adolescents and children aged 18 years or younger have not been established.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • impaired left ventricular contractile function
  • decreased left ventricular ejection fraction
View approved original text

This medication is used to control essential hypertension, which is high blood pressure of unknown origin. It is also effective for patients with heart failure, particularly those with left ventricular ejection fraction of 40% or less. It may help slow the progression of heart failure and improve heart function. It is used as an alternative treatment for patients who are undergoing ACE inhibitor therapy but require additional treatment or cannot tolerate ACE inhibitors well. This medication stabilizes blood pressure and reduces cardiac workload, thus enhancing overall cardiovascular health. Therefore, it is used to treat essential hypertension and heart failure with reduced left ventricular function.

How to take

Adult dose

This drug should be taken at the same time each day, with or without food. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil, administered orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks after starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: For patients at increased risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful attention. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks and increased up to a maximum of 32 mg once daily, taking the patient's tolerability into account. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension The safety and efficacy in adolescents and children aged 18 years or younger have not been established. 2. Heart failure The safety and efficacy in adolescents and children aged 18 years or younger have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. This medication should not be taken by individuals who are allergic to it or its components, women who are pregnant or breastfeeding, patients with severe liver disease or biliary obstruction, certain hereditary angioedema patients, primary aldosteronism patients, or those with lactose intolerance. Elderly individuals, patients with hyperkalemia, liver disease, heart valve disease, ischemic heart disease, or cerebrovascular disorders, patients with renal artery stenosis, those with reduced intravascular blood volume, reduced kidney function, recent kidney transplant recipients, and children and adolescents under 18 years should use this medication with caution. Possible side effects include dizziness, back pain, respiratory infections, and, in rare cases, serious side effects such as blood abnormalities, liver dysfunction, angioedema, rhabdomyolysis, and acute kidney failure. If any abnormal symptoms occur, consult a doctor immediately. Patients with heart failure or reduced kidney function should have their serum potassium and creatinine levels monitored regularly, as well as close observation of blood pressure and renal function. There may be interactions with other antihypertensive agents, potassium-sparing diuretics, and nonsteroidal anti-inflammatory drugs, so if you are taking other medications, be sure to inform your healthcare provider. Women who are planning to become pregnant or may be pregnant should not take this medication, and breastfeeding women should avoid taking it or stop breastfeeding. Safety and efficacy for individuals under 18 years have not been established, so it is advisable not to use it in this age group. For the elderly, there is a risk of excessive blood pressure lowering leading to conditions such as cerebral infarction, so care should be taken when administering. In case of overdose, symptoms such as symptomatic hypotension, dizziness, or rapid heartbeat may occur, and immediate medical attention should be sought for appropriate treatment. This medication should be stored out of reach of children and not transferred to other containers for safety.

Side effects

  • Dizziness
  • Low back pain
  • Respiratory infection
  • Asthenia
  • Fever
  • Perceptual disturbances
  • Dyspepsia
  • Gastroenteritis
  • Tachycardia
  • Palpitations
Show 67 more
  • Increased creatine kinase
  • Hyperglycemia
  • Hypertriglyceridemia
  • Hyperuricemia
  • Myalgia
  • Epistaxis
  • Anxiety
  • Depression
  • Somnolence
  • Dyspnea
  • Rash
  • Increased sweating
  • Hematuria
  • Hypotension
  • Hyperkalemia
  • Renal impairment
  • Increased creatinine
  • Increased urea
  • Fatigue
  • Peripheral edema
  • Chest pain
  • Headache
  • Bronchitis
  • Cough
  • Sinusitis
  • Nausea
  • Abdominal pain
  • Diarrhea
  • Vomiting
  • Arthralgia
  • Proteinuria
  • Leukopenia
  • Neutropenia
  • Agranulocytosis
  • Hyponatremia
  • Hypoglycemia
  • Intestinal vessel edema
  • Increased liver enzyme levels
  • Hepatitis
  • Increased AST
  • Increased ALT
  • Increased γ-GTP
  • Jaundice
  • Urticaria
  • Itching
  • Angioedema
  • Rhabdomyolysis
  • Increased myoglobin in blood and urine
  • Acute renal failure
  • Interstitial pneumonia
  • Shock
  • Syncope
  • Loss of consciousness
  • Paralysis
  • Hypertonia
  • Facial flushing
  • Weight gain
  • Facial edema
  • Thirst
  • Sleep disturbance
  • Decreased libido
  • Amnesia
  • Anorexia
  • Increased appetite
  • Tinnitus
  • Taste disturbance
  • Erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to avoid exposure to air or moisture. It is best kept at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Light pink, round tablets with a convex shape on both sides

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.